Yossef, R., Gur, C., Shemesh, A., Guttman, O., Hadad, U., Nedvetzki, S. ... Porgador, A. (2015). Targeting Natural Killer Cell Reactivity by Employing Antibody to NKp46: Implications for Type 1 Diabetes. PLOS ONE, 10. (2). doi: 10.1371/journal.pone.0118936
Yossef, Rami, et al. "Targeting Natural Killer Cell Reactivity by Employing Antibody to NKp46: Implications for Type 1 Diabetes." PLOS ONE, vol. 10, no. 2, 2015. https://doi.org/10.1371/journal.pone.0118936
Yossef, Rami, Chamutal Gur, Avishai Shemesh, Ofer Guttman, Uzi Hadad, Shlomo Nedvetzki, Antonija Miletić, et al. "Targeting Natural Killer Cell Reactivity by Employing Antibody to NKp46: Implications for Type 1 Diabetes." PLOS ONE 10, no. 2 (2015). https://doi.org/10.1371/journal.pone.0118936
Yossef, R., et al. (2015) 'Targeting Natural Killer Cell Reactivity by Employing Antibody to NKp46: Implications for Type 1 Diabetes', PLOS ONE, 10(2). doi: 10.1371/journal.pone.0118936
Yossef R, Gur C, Shemesh A, Guttman O, Hadad U, Nedvetzki S, and sur.. Targeting Natural Killer Cell Reactivity by Employing Antibody to NKp46: Implications for Type 1 Diabetes. PLOS ONE [Internet]. 2015 February 26 [cited 2024 September 01];10(2). doi: 10.1371/journal.pone.0118936
R. Yossef, et al., "Targeting Natural Killer Cell Reactivity by Employing Antibody to NKp46: Implications for Type 1 Diabetes", PLOS ONE, vol. 10, no. 2, February 2015. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:468753. [Accessed: 01 September 2024]